首页> 外文期刊>Natural product research >Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4′-leucine-avarone
【24h】

Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4′-leucine-avarone

机译:海洋天然产物衍生物4'-亮氨酸-阿瓦隆的细胞毒性的进一步体外评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The cytotoxicity of 4′-leucine-avarone, amino derivative of the sponge Dysidea avara secondary metabolite avarone, was evaluated by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide assay in vitro against seven human solid tumours for the first time. The compound tested induced dose-dependent cytotoxic response in all cancer cells showing better activity towards the lung A-549 and colon HT-29 cell lines (IC50 7.40 μM and 9.62 μM, respectively) than towards the breast adenocarcinoma ER positive MCF-7 and ER negative MDA-MB-231 cells (IC50 11.64 μM and 17.31 μM, respectively), the prostate adenocarcinoma PC-3 and epiteloid cervix carcinoma HeLa cells (IC50 14.24 μM and 15.54 μM, respectively). No toxicity was found towards the foetal lung fibroblast MRC-5 cell line at the concentrations used. According to experimental data obtained, the sesquiterpenoid quinone structure of avarone may inspire development of new drug-like substances with improved cytotoxicity on lung cancer in humans.
机译:用3- [4,5-二甲基噻唑-2-基] -2,5-二苯基溴化四氮唑测定体外对海绵Dysidea avara次生代谢产物Avarone的氨基衍生物4'-亮氨酸-avarone的细胞毒性。人类实体瘤首次出现。测试的化合物在所有癌细胞中均表现出剂量依赖性的细胞毒性反应,其对肺A-549和结肠HT-29细胞系的活性(分别为IC50,分别为7.40μM和9.62μM)比对乳腺腺癌ER阳性的MCF-7和ER阴性MDA-MB-231细胞(IC50分别为11.64μM和17.31μM),前列腺腺癌PC-3和表皮宫颈癌HeLa细胞(IC50分别为14.24μM和15.54μM)。在所用浓度下未发现对胎儿肺成纤维细胞MRC-5细胞系有毒性。根据获得的实验数据,阿瓦隆的倍半萜醌结构可能会激发新的药物样物质的发展,从而改善对人类肺癌的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号